Navigating challenges in drug‐coated balloon technology: The saga between paclitaxel and sirolimus continues
Catheterization and Cardiovascular Interventions · 2024-09 · 104 (3) · 521-522
DOI: 10.1002/ccd.31164 ↗Kurz gefasst
Leserbrief in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 30.07.2024. Verfasst von Bernardo Cortese und 4 weiteren Autor:innen. Beteiligte Einrichtung: Fondazione Ricerca e Innovazione Cardiovascolare, Milano, Italy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Fondazione Ricerca e Innovazione Cardiovascolare, Milano, Italy.
- DCB Academy, Milano, Italy.
- University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
- Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
- CVPath Institute, Gaithersburg, Maryland, USA.
- University of Maryland School of Medicine, Baltimore, Maryland, USA.
Zitieren
APA
Cortese, B., Tensol, G. R. P., Dallan, L. A. P., Salerno, P. R. V. O., & Finn, A. (2024). Navigating challenges in drug‐coated balloon technology: The saga between paclitaxel and sirolimus continues. Catheterization and Cardiovascular Interventions, 104(3), 521-522. https://doi.org/10.1002/ccd.31164
Vancouver
Cortese B, Tensol GRP, Dallan LAP, Salerno PRVO, Finn A. Navigating challenges in drug‐coated balloon technology: The saga between paclitaxel and sirolimus continues. Catheterization and Cardiovascular Interventions. 2024;104(3):521-522. doi:10.1002/ccd.31164
BibTeX
@article{Cortese2024,
author = {Cortese, Bernardo and Tensol, Gabriel Rodrigues Pereira and Dallan, Luis Augusto Palma and Salerno, Pedro Rafael Vieira de Oliveira and Finn, Aloke},
title = {Navigating challenges in drug‐coated balloon technology: The saga between paclitaxel and sirolimus continues},
journal = {Catheterization and Cardiovascular Interventions},
year = {2024},
volume = {104},
number = {3},
pages = {521--522},
doi = {10.1002/ccd.31164}
}
EUVIMED